NantHealth, Inc
NH was delisted on the 23rd of May, 2023.
0 hedge funds and large institutions have $0 invested in NantHealth, Inc in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 17 closing their positions.
3.51% less ownership
Funds ownership: 3.51% → 0% (-3.5%)
100% less funds holding
Funds holding: 18 → 0 (-18)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $542K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 17
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Highbridge Capital Management
New York
|
-$290K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$129K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$54.4K |
| 4 |
Bridgeway Capital Management
Houston,
Texas
|
-$37K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$24.6K |
NH Hedge Fund Activity: Q2 2023 in Review
0 of the 6,389 institutional investors tracked by Wall St. Rank reported a position in NantHealth, Inc (NH) for Q2 2023, worth a combined $0 — down 100% from $542K a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of NH and 0 opened new positions — a net loss of 17 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Highbridge Capital Management, exiting entirely with an estimated $290K sold.
- 0 institutional investors held NantHealth, Inc (NH) as of Q2 2023, down from 18 in Q1 2023.
- Funds reported $0 of NantHealth, Inc stock for Q2 2023, down 100% quarter-over-quarter.
- 0 funds opened new NantHealth, Inc positions in Q2 2023 and 17 closed out, a net change of -17 holders.
- The largest NantHealth, Inc seller in Q2 2023 was Highbridge Capital Management, an estimated $290K sold.
Based on aggregated 13F filings for Q2 2023.